Private Label Azelaic & Glycolic Acid Serum Manufacturer Low MOQ

The minimum order quantity for a private label azelaic acid and glycolic acid serum varies significantly based on whether you are using a stock (off-the-shelf) formula or commissioning a custom formulation. For stock formulas where the manufacturer already has a validated azelaic/glycolic blend, MOQs can run as low as 100–150 filled units, sometimes even 50 units if you supply your own packaging. Custom development almost always requires a higher commitment — most cosmetic chemistry labs set their custom-development MOQ between 300 and 1,000 units to recover development costs across the run. Several factors push MOQ up or down. Packaging format is one of the biggest levers: if you choose the manufacturer's in-house stock packaging (a standard airless pump or glass dropper they already inventory), they can run smaller batches efficiently. Switching to a proprietary bottle or custom-printed component forces them to hold unique components, which raises their carrying cost and therefore their minimum. Active concentration also matters — azelaic acid above 15% requires extended milling time (the ingredient is a solid powder that must be micronized into the base), which increases batch cost and may push the break-even MOQ higher. Geography plays a role too. US-based GMP facilities tend to have lower MOQs (100–500 units is common) versus large Asian contract manufacturers whose economics favor runs of 3,000–10,000 units, though the per-unit cost is often considerably lower at scale. European manufacturers sit somewhere in between, often at 500–2,000 unit minimums, and they frequently include EU Responsible Person (RP) filing assistance in the scope, which adds value for brands targeting the EU market. If you are launching an indie brand with limited capital, a practical strategy is to start with a stock formula at a 100–200 unit MOQ to validate market demand, then commission a custom development run once you have sales data. AJ Cosmo Labs makes it easy to filter manufacturers by MOQ directly inside the iOS app, so you're never wasting time emailing a supplier whose minimums are ten times your launch volume. One common mistake first-timers make is accepting an MOQ that's too high because they didn't negotiate. MOQ is often more flexible than the number on a supplier's website suggests — especially if you agree to longer payment terms, prepay raw materials, or commit to a second run within 12 months. Always negotiate.

The total cost to private label an azelaic acid and glycolic acid serum has two distinct buckets: development costs (one-time) and per-unit production costs (recurring). Understanding both is critical for building an accurate COGS model before you commit to a manufacturer. Development costs typically range from $1,500 to $8,000 for a custom formula. This covers the cosmetic chemist's time, raw material procurement for lab batches, prototype iterations (usually 2–4 rounds), and accelerated stability testing. If you add third-party panel testing (repeat insult patch test, ophthalmologist-tested claims) or EU safety assessment, expect to add another $2,000–$5,000. Some manufacturers amortize development costs into the per-unit price across the first run — this looks cheaper upfront but inflates your COGS in year one. Per-unit production costs for a filled-and-capped serum (excluding label and outer carton) typically break down as follows: at 100–300 units, expect $10–$18 per unit; at 500–2,000 units, $6–$10; at 2,500–10,000+, $3–$6. The wide range within each tier reflects differences in active concentration (higher azelaic acid loads cost more because the raw material is more expensive per kg than most AHA powders), packaging format (glass airless pumps can add $1.50–$3.00 per unit over a basic HDPE bottle), and fill labor (viscous or particle-laden formulas take longer to fill, raising labor cost). Azelaic acid is notably more expensive than glycolic acid as a raw material — pharmaceutical-grade azelaic acid (dicarboxylic acid 99%+ purity) runs roughly $30–$70 per kg depending on supplier and quantity, while cosmetic-grade glycolic acid is $8–$20 per kg. A 10% azelaic, 7% glycolic formula in a 30 mL bottle uses a meaningful quantity of both, so raw material cost per unit is not trivial at small batch sizes. Labeling, carton, and shrink wrap add another $0.30–$1.50 per unit depending on print complexity. Freight from the manufacturer to your 3PL or storage adds $0.20–$0.80 per unit for domestic US shipments. Budget a full landed COGS of $12–$22 per unit at a 200-unit indie run, or $5–$9 at a 2,000-unit mid-tier run, before applying your brand margin. A common mistake founders make is forgetting to factor stability testing into their budget timeline — it is not optional for an acid serum. Skipping accelerated stability to save $500–$2,000 exposes you to real liability if the formula degrades, crystallizes, or changes pH in the bottle within 12 months of manufacture. Budget for it from day one. Posting a detailed brief on AJ Cosmo Labs, including your target active concentrations and packaging format, lets multiple suppliers quote you on the same spec simultaneously — which is the fastest way to benchmark real market pricing without weeks of back-and-forth.

The end-to-end timeline from initial brief to first shipment of a private label azelaic acid and glycolic acid serum typically runs 10–20 weeks for a custom development, or 6–10 weeks if you use a validated stock formula. Here is how each stage breaks down. Weeks 1–2 are brief, NDA, and supplier selection. Once you've identified a shortlist of manufacturers, sharing a detailed brief (active percentages, pH target, delivery texture, any 'free-from' claims, packaging format, and timeline) allows suppliers to come back with a formal quote and proposed INCI list. Expect 5–10 business days for a quality response. Weeks 2–5 are lab batch and prototype development. The cosmetic chemist formulates initial lab batches, which are typically 100–500 g quantities. For azelaic acid serums specifically, this stage often takes longer than a simple emulsion because micronizing or solubilizing azelaic acid into a stable serum base is technically demanding. First prototype shipment to you for sensory review (texture, slip, finish, dry-down) usually happens around week 3–4. Weeks 5–8 cover iteration and formula lock. Most projects require 1–3 revision rounds — adjusting viscosity, tweaking the humectant system to counteract glycolic acid's drying tendency, or fine-tuning pH to balance efficacy and skin feel. Formula lock should happen no later than week 8 to avoid cascading delays. Weeks 8–18 are accelerated stability testing. This is the most time-consuming non-negotiable stage. ICH-standard accelerated stability at 40 °C / 75% RH runs a minimum of 8 weeks, with interim reads at 4 weeks. Real-time ambient stability runs concurrently but doesn't deliver data in time to gate production. Packaging compatibility testing (to confirm your airless pump or glass dropper doesn't interact adversely with the low-pH formula) also runs during this window. Weeks 14–20 are scale-up, production fill, and QC. Once stability data is satisfactory, the cosmetic chemist transfers the formula to production batch. GMP batch records are completed, finished-goods CoA is issued, and product is held for release testing before shipping. Shipping to your warehouse or 3PL adds 3–7 business days domestically. Timeline risk factors that extend the schedule include formula instability (forces another development iteration), packaging sourcing delays (lead times on glass airless bottles have been 10–16 weeks post-2022), regulatory review if targeting the EU or Canada, and high manufacturer workload in Q3–Q4. Build a 4-week buffer into any launch plan. Using AJ Cosmo Labs to post your brief to multiple vetted manufacturers simultaneously rather than going sequentially can compress the supplier selection phase from 4–6 weeks to 1–2 weeks — a meaningful saving on a 16-week project.

In the United States, most glycolic acid and azelaic acid serums marketed as cosmetics do not require FDA pre-market approval. The FDA regulates cosmetics under the Federal Food, Drug, and Cosmetic Act (FD&C Act), which does not require a company to register products, file formulas, or obtain approval before selling. However, 'cosmetic' has a precise legal meaning, and acid serums can easily cross the line into drug territory based on their marketing claims. A product is classified as a drug — not a cosmetic — if it is intended to affect the structure or function of the body or to treat a disease. For glycolic acid serums, claims like 'clinically treats acne,' 'reduces acne lesions by 40%,' or 'treats hyperpigmentation caused by melasma' are drug claims. If your marketing — including your website, labeling, social posts, or any promotional material — contains such language, the FDA can classify your serum as an unapproved new drug, which is a serious enforcement risk. Safe cosmetic positioning typically uses language like 'visibly reduces the appearance of uneven skin tone,' 'helps skin look smoother over time,' or 'exfoliates to reveal brighter-looking skin.' Your cosmetic chemist and a regulatory consultant can help you draw this line correctly during label review. Concentration thresholds matter too. The Cosmetic Ingredient Review (CIR) has assessed AHAs including glycolic acid and concluded they are safe at concentrations up to 10% in rinse-off products and up to 10% in leave-on products at pH 3.5 or above, when the product contains adequate UV protection instructions or sun-sensitivity warnings. Formulas exceeding these parameters are not automatically illegal, but they attract more FDA scrutiny and may warrant additional safety testing. Azelaic acid at cosmetic concentrations (typically 10% or under in a leave-on serum) is generally treated as a cosmetic ingredient in the US. At 15–20%, it is the concentration used in FDA-approved prescription products (Finacea, Azelex) for rosacea and acne — so a 20% leave-on serum sold OTC with drug claims would be a significant regulatory red flag. The Modernization of Cosmetics Regulation Act (MoCRA), effective December 2023, adds new requirements: facility registration with the FDA, cosmetic product listing, and a Serious Adverse Event Reporting (SAER) obligation. These apply to almost all US cosmetic companies and are not optional regardless of company size. For brands targeting the EU, the regulatory picture is stricter. Annex III of the EU Cosmetics Regulation (EC 1223/2009) restricts AHAs and requires a mandatory on-label warning: 'Contains AHA. Avoid sun exposure. Use sunscreens.' A Cosmetic Product Safety Report (CPSR) prepared by a qualified EU Safety Assessor is mandatory before market entry, and a Responsible Person (RP) established in the EU or UK must be named on the label. If you are uncertain about classification, a one-hour call with a US cosmetic regulatory consultant typically costs $200–$500 and can save you from a much more expensive problem later.

Azelaic acid and glycolic acid are both widely used cosmetic actives, but they work through different mechanisms, come from different source categories, present different formulation challenges, and serve different (though sometimes overlapping) consumer skin concerns. Understanding the difference matters when briefing a cosmetic chemist for a private label blend. Glycolic acid is an alpha-hydroxy acid (AHA) derived from sugarcane. It is water-soluble, has the smallest molecular weight of any AHA, and penetrates the stratum corneum readily. Its primary mechanism in a leave-on serum is chemical exfoliation: at low pH (typically 3.0–3.8), it disrupts the ionic bonding between corneocytes, accelerating desquamation and revealing fresher skin cells underneath. Consumer benefits include smoother texture, reduced appearance of fine lines, and improved skin radiance. It is also used as a pH adjuster in formulations because it is both the active and an acid. Azelaic acid is a naturally occurring dicarboxylic acid found in grains (wheat, barley, rye) and also produced synthetically for cosmetic and pharmaceutical use. Unlike glycolic acid, it does not primarily function as an exfoliant. Its mechanisms are tyrosinase inhibition (reducing melanin synthesis in hyperpigmented areas), mild comedolytic activity, and anti-inflammatory properties relevant to redness and post-inflammatory hyperpigmentation. It works at a wider pH range (up to pH 5.0) compared to glycolic acid, which requires a low-pH environment to be efficacious. From a formulation chemistry standpoint, the two actives present very different challenges. Glycolic acid is easy to solubilize and incorporate but demands precise pH control — too high and it loses efficacy, too low and it may cause irritation or cross the line into drug territory. Azelaic acid is a solid powder at room temperature with poor water solubility at typical cosmetic concentrations. At 10% and above, it tends to crystallize in a water phase serum unless the cosmetic chemist uses a solubilizing co-solvent system (such as a propylene glycol or pentylene glycol blend) or micronizes the particle to a specific distribution. Crystal formation in a finished serum is a major product stability failure. Formulating the two together in a single serum requires the cosmetic chemist to satisfy the pH requirements of both actives — azelaic acid does not demand a sub-4.0 pH to function, but glycolic acid does. A compromise around pH 3.5–4.0 is typically the target window. This still requires careful buffering to prevent the formula from drifting upward during shelf life. Consumer communication is an important brand consideration. Many founders choose the combination because it addresses a dual use case: glycolic acid for overall exfoliation and texture refinement, azelaic acid for spot hyperpigmentation and redness. The blend appeals to consumers with skin concerns that overlap (post-acne marks plus uneven tone, for example), giving the product a broader addressable market than a single-active formula. When briefing a cosmetic chemist through AJ Cosmo Labs, specify both your target percentage for each active and your desired finished formula pH — this information dramatically reduces back-and-forth in the proposal stage and lets the chemist quote you accurately from the outset.

Finding a vetted private label manufacturer specifically experienced in acid-based serums at low MOQs requires more diligence than sourcing a simple lotion or shampoo co-packer. The combination of low pH chemistry, active-ingredient stability requirements, and regulatory complexity means you need a manufacturer with genuine cosmetic chemistry capability — not just a toll-fill facility that will accept your formula without reviewing it. The traditional routes — trade directories like ThomasNet or Maker's Row, trade shows like NYSCC Suppliers' Day or the Cosmoprof exhibition — can surface candidates but require extensive vetting on your part. Most directories do not screen for chemistry competence, GMP compliance, or minimum order flexibility. You may spend 4–6 weeks emailing suppliers and collecting questionnaires before you identify a shortlist of two or three legitimate candidates. When evaluating any manufacturer, the non-negotiable questions are: Do you have licensed cosmetic chemists on staff? Can you provide your most recent GMP audit report or ISO 22716 certificate? What is your in-house stability testing capability (temperature and humidity chambers, time-points offered)? Have you manufactured acid serums at concentrations above 10% before? What is your quality hold-and-release process for finished goods? If a supplier cannot answer all of these with specifics, move on. Green flags in a supplier response include: a clear NDA workflow before sharing formula details, a formal quotation that breaks out development fees separately from per-unit fill cost, a proposed project timeline with named milestones, and willingness to provide reference clients in a similar product category (acid serums, exfoliants, low-pH treatments). Red flags include: no mention of stability testing in their process, unwillingness to share a GMP audit certificate, an MOQ that is identical for every product regardless of formula complexity, and quotes that arrive within hours with no questions asked — a sign the supplier did not read your brief carefully. Regional considerations matter. US-based manufacturers are typically the easiest starting point for US-market brands: they are subject to MoCRA, familiar with FTC claims substantiation, and logistically simpler. If you plan to sell in the EU from launch, look for a manufacturer with experience supporting EU Cosmetic Product Safety Reports and EU Responsible Person arrangements — not all US facilities have this experience. AJ Cosmo Labs was built specifically to solve this discovery and vetting problem. The iOS app lets you post a single brief with your active concentrations, target pH, packaging format, and MOQ, and receive responses from pre-vetted cosmetic chemists and contract manufacturers — including acid-serum specialists. All suppliers on the platform have been reviewed before access is granted, and you can message them directly, track sample shipments, and release milestone payments through escrowed transactions inside the app. Download AJ Cosmo Labs on the App Store and post your brief today to start comparing qualified quotes in days rather than months.

Stability testing for an azelaic acid and glycolic acid serum is not optional — it is a fundamental requirement for any brand that intends to sell a cosmetic product legally and responsibly in any major market. For acid serums specifically, stability testing is more demanding than for a simple moisturizer because you are managing two chemically active ingredients, a low and tightly controlled pH, and potential physical instability from azelaic acid's tendency to crystallize. The core battery of stability tests for a leave-on acid serum includes the following. Accelerated stability testing runs samples at 40 °C and 75% relative humidity for a minimum of 8 weeks (some manufacturers run 12 weeks), with evaluation at 4-week and 8-week intervals. This simulates approximately 24 months of real-time shelf life when conducted under ICH Q1A guidelines, though this equivalence is an estimate, not a guarantee. Parameters evaluated at each interval include: pH (critical for a glycolic acid serum — a drift of 0.3 pH units or more in either direction is a failure signal), appearance and color, viscosity, odor, microbial counts (if preservative system is included, which it must be for a water-based formula), and — crucially for azelaic acid serums — visual inspection for crystal formation or sedimentation. Real-time stability runs concurrently at ambient conditions (typically 20–25 °C, 45–65% RH) and provides true shelf-life data over time. A 24-month shelf-life claim requires 24 months of real-time data; you cannot shortcut to a 'guaranteed 24-month' claim based on accelerated data alone, particularly in the EU. Packaging compatibility testing is a distinct but related requirement. The finished serum (at its working pH of 3.0–4.0) must be tested in actual production packaging — the specific pump mechanism, inner liner material, and container — for at least 8–12 weeks under accelerated conditions. Low-pH formulas can leach plasticizers from PET containers, corrode metal spring components inside pumps, or interact with adhesive labels. These failures are invisible until the product is already in trade. Freeze-thaw cycling is recommended for any serum that will be distributed in regions with significant temperature variation. Typically 3–5 cycles of freezing (−10 °C to −20 °C) followed by thawing at room temperature are run to check for phase separation or crystal formation in azelaic acid formulas. Microbial challenge testing (also called preservative efficacy testing or PET) confirms that the preservative system prevents microbial growth when the product is intentionally inoculated with specific organisms per USP or ISO 11930 protocols. A water-based serum at low pH may benefit somewhat from the acidic environment as a mild antimicrobial, but this is not a substitute for validated preservative efficacy data. In the EU, all cosmetic stability data must be compiled as part of the Cosmetic Product Safety Report (CPSR) evaluated by a qualified safety assessor. The assessor will not sign off without stability data meeting EU Cosmetics Regulation Annex I requirements. In the US under MoCRA, while a CPSR equivalent is not yet mandated in the same form, brands are required to have 'adequate substantiation of safety,' which in practice means stability and safety data on file. The total cost of a full stability program for an acid serum — accelerated, real-time, freeze-thaw, packaging compatibility, and microbial challenge — typically runs $2,500–$6,000 at a US contract testing laboratory. Budget for it early and build the 8–12-week window into your launch timeline from day one.